Bill Miller
Miller Value Partners
Miller Value Partners Portfolio 13F
Bill Miller Holdings Activity
- Portfolio value:
- $2.33B≈ (+$22M≈)
- Previous value:
- $2.31B≈
- # of changes:
- 82
- New positions:
- 7
- Reported for:
- 31 Mar 2018 (Q1)
- Latest filing date:
- 15 May 2018
Miller Value Partners has disclosed a total of 82 changes to the portfolio in the (2018 Q1) SEC report(s): increased the number of shares of 33, bought 7 totally new, decreased the number of shares of 35 and completely sold out 7 position(s).
What stocks did Bill Miller buy in 2018 Q1?
During 2018 Q1 Bill Miller has bought 40 securities out of which top 5 purchases (by % change to portfolio) were (PGEN) Precigen Inc (added shares +4.93%), (LUMN) Lumen Technologies Inc (added shares +28.03%), (ENDPQ) ENDO HEALTH SOLUTIONS INC COM (added shares +23.12%), (GNW) Genworth Financial Inc (added shares +3.11%) and (AGN) ACTAVIS INC COM STK (NV) (added shares +70.82%).
In the 2018 Q1 report(s) the following changes have been made to the top investments: (AMZN) Amazon.com Inc (reduced shares -3.90%), (RH) RH (reduced shares -2.16%), (OMF) OneMain Holdings Inc (reduced shares -2.11%), (VRX) Valeant Pharmaceuticals International Inc (reduced shares -19.77%) and (DAL) Delta Air Lines Inc (reduced shares -5.84%).
82 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Barclays PLC ADR
|
new
|
$11.86
|
+137.72%($28.20)
|
0.01%
|
2018 Q1
|
≈ 0.25 years
|
||||
|
|
CYS Investments Inc
|
new
|
$6.72
|
|
0.23%
|
2018 Q1
|
≈ 0.25 years
|
||||
|
|
NEXPOINT STORAGE PARTNERS IN
|
new
|
$18.10
|
+14.12%($20.66)
|
0.10%
|
2018 Q1
|
≈ 0.25 years
|
||||
|
|
Micron Technology Inc
|
new
|
$52.14
|
+1,627.25%($900.59)
|
0.45%
|
2018 Q1
|
≈ 0.25 years
|
||||
|
|
ProShares UltraPro QQQ
|
new
|
$71.97
|
+4.04%($74.88)
|
0.06%
|
2018 Q1
|
≈ 0.25 years
|
||||
|
|
SunCoke Energy Partners L.P
|
new
|
$17.80
|
|
0.07%
|
2018 Q1
|
≈ 0.25 years
|
||||
|
|
Unisys Corp
|
new
|
$10.73
|
-71.66%($3.04)
|
0.01%
|
2018 Q1
|
≈ 0.25 years
|
||||
|
|
Celgene Corp
|
+18,720.68%
|
$89.21
|
|
1.58%
|
2017 Q2
|
≈ 1.00 year
|
||||
|
|
Teva Pharma Industries Ltd ADR
|
+325.29%
|
$17.09
|
+101.08%($34.36)
|
1.61%
|
2017 Q4
|
≈ 0.50 years
|
||||
|
|
Western Asset Mortgage Capital
|
+159.82%
|
$96.92
|
|
0.06%
|
2017 Q2
|
≈ 1.00 year
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.